20/11/2017 - 11:23 RNS
RNS Number: 9770W ValiRx PLC 20 November 2017 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Valirx PLC 1b. Please ...
15/11/2017 - 16:37 RNS
RNS Number: 6282W ValiRx PLC 15 November 2017 Va li R x P lc ("ValiRx" or "the Company" or "the Group") Loan Note Conversion and Issue of Equity London, UK ., 15 November 2017: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines ...
11/10/2017 - 07:06 StockMarketWire
ValiRx said its joint venture with Tangent Reprofiling has obtained a new US patent allowance. The clinical stage therapeu...
11/10/2017 - 06:00 RNS
RNS Number: 2470T ValiRx PLC 11 October 2017 VALIRX PLC ("ValiRx", the "Company" or the "Group") NOTIFICATION OF US PATENT ALLOWANCE FOR THERAPEUTIC COMPOUND, VAL401 London, UK ., 11 October 2017: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company , is pleased to report that ValiSeek Limited ("ValiSeek"), the join...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment